GlaxoSmithKline to Pay $105 Million to Settle Claims Over the Promotion of its Antidepressants and A

GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs. Flood Law Group is investigating potential Paxil claims in light of this recent settlement. (PRWEB) June 27, 2014 GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs, including Paxil(Bloomberg “Glaxo to Pay $105 Million to Settle Promotion Claims” June 2, 2014). In light
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories